Portal Vein Thrombosis (PVT)
Pakinam Mekki
Background
- Portal Vein Thrombosis (PVT) can worsen decompensation (i.e. variceal hemorrhage), however, worsening portal HTN à more sluggish flow à increased risk PVT
Presentation
- Often identified asymptomatically on U/S, but can be identified by new or worsening decompensation of portal HTN
- Variceal hemorrhage is the most common decompensating event associated with PVT
- Intestinal ischemia (abdominal pain, hematochezia) from PVT is exceedingly rare but associated with significant morbidity/mortality
Evaluation
- RUQ U/S with doppler
- Once identified, should be further assessed with triple phase CT or MRI with Gadovist contrast to exclude HCC with tumor thrombus
- Pts with newly identified PVT should undergo EGD to evaluate for high-risk varices, both for diagnostic and therapeutic considerations
- PVT in pts without cirrhosis should prompt evaluation for hypercoagulable disorders
Management
- Start AC if acute thrombus occludes >50% of main portal vein, <50% but extends into SMV, thrombus is symptomatic, or patient is a transplant candidate (irrespective of size). Requires discussion with attending/transplant team.
- AC options: warfarin, LMWH, or DOAC
- DOAC’s are safe in Childs Class A, can be used with caution in Childs B, and are contraindicated in Childs C
- Pts with chronic occlusive PVT (>6 mos) or with cavernous transformation with collaterals do not generally benefit from AC
- Pts with high-risk varices should undergo endoscopic management or be on NSBB for prophylaxis for variceal hemorrhage, as noted above
- TIPS with portal vein recanalization has recently emerged as a therapeutic modality for PVT in LT candidates to allow for anastomosis, in patient’s with chronic PVT and recurrent bleeding/refractory ascites, or in patients whom intestinal ischemia persists despite AC.
- Pts should undergo follow up intermittently with US to assess for recanalization. AC may be stopped if there is failure to recanalize.
- If pts are not candidates for AC, they’ll simply be treated for complications of portal HTN